Self-Paced Heat Acclimation Procedures

The purpose of this investigation was to evaluate thh effectiveness of self-paced heat acclimation (SPHA) procedures. fourteen males performed 100 nmin of intermittent exercise during 9 SPHA work-rest cycles, on eight days. Exercise consisted of 8.279 P or - 0.527 to 9.799 + or - 0.433 km of treadmi...

Full description

Saved in:
Bibliographic Details
Main Authors: Armstrong,Lawrence E, Hubbard,Roger W, DeLuca,Jane P, Christensen,Elaine L
Format: Report
Language:English
Subjects:
ACCLIMATIZATION
ARMY PERSONNEL
ARMY TRAINING
AS879
BODY TEMPERATURE
CASUALTIES
ENDURANCE(PHYSIOLOGY)
EXPOSURE(PHYSIOLOGY)
HEART RATE
HEAT STRESS(PHYSIOLOGY)
HEAT TOLERANCE
ILLNESS
MILITARY EXERCISES
PE62777A
PHYSICAL FITNESS
RECRUITS
Rectal temperature
Stress Physiology
SWEAT GLANDS
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The purpose of this investigation was to evaluate thh effectiveness of self-paced heat acclimation (SPHA) procedures. fourteen males performed 100 nmin of intermittent exercise during 9 SPHA work-rest cycles, on eight days. Exercise consisted of 8.279 P or - 0.527 to 9.799 + or - 0.433 km of treadmill running per day. SPHA trials were effective in improving heat tolerance in that significant (p .05) reductions were observed (day 1 vs day 8) in final heart rate (HR), Delta HR, final rectal temperatures (Tre), Delta Tre, final mean weighted skin temperature (Tsk), and Delta Tsk. Resting plasma volume expanded significantly (p . 05) from day 1 to day 4, but sweat rate was unchanged. Group mean exercise intensities and ratings of perceived exertion were not statistically different from days 2 - 7, let the number of trials terminate because subjects exceeded HR and Tre safety limits (22 out of 112 trials) declined during heat acclimation (days 1-4 = 16, days 5-8 = 6). Symptoms of heat illness (piloerection, chills, dizziness, vomiting) were observed in 16.1% of all trials; 11 out of 14 subjects (78.6%) experienced one or more or these symptoms during SPHA trials.